~~<i id='8D62B727A8'><strike id='8D62B727A8'><tt id='8D62B727A8'><pre id='8D62B727A8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：entertainment 2025-09-30 14:58:10 - browse：31

Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

focus

explore

knowledge

hotspot

entertainment

0:37CanadianPrimeministerJustinTrudeauandwifeSophieTrudeauinLondon,May6,2023.JacobKing-PaImages/PAIm

WSS

Do digital therapeutics have a future in medicine?

What the US credit downgrade means for the economy, your finances

Adults seen as increasingly susceptible to measles

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

What we need to know about Arena Bioworks

Medicare drug price negotiation’s day in court

knowledge

Wikipedia

focus

Heart attack and stroke risk calculators need revising

Mitch McConnell episode has important public health takeaway

Activists slam private health insurers over coverage restrictions

Woodcock on FDA’s accelerated approval and her next chapter

United colonoscopy coverage change 'may cost lives,' doctors say

Mega Millions pot grows to $1.25 billion after no winner

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden administration opens offers in Medicare drug price negotiations

Medical records are filled with copy

FDA drug safety: Singulair case shows systemic surveillance flaws

explore

New safety details link Apellis eye drug to rare cases of blindness

What the US credit downgrade means for the economy, your finances

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

What the airline industry can learn from medicine

Pence says 'crackpot lawyers' told Trump what he wanted to hear

knowledge

knowledge

hotspot

entertainment